barium sulfate



Moovly Media Inc.
Latest Comments
image_pdfimage_print

Brent Willis of Voyageur Pharmaceuticals discusses the high IRR and NPV in its recent PEA

In a recent InvestorIntel interview, Tracy Weslosky spoke with Brent Willis, President and CEO of Voyageur Pharmaceuticals Ltd. (TSXV: VM) about […]


Voyageur Pharmaceuticals’ X-Ray Contrast Media Provides a Dramatic Increase in Valuation

Assuming you aren’t a meme stock or an equity driven by the Reddit army, then you know you’ve told the […]


Voyageur Pharmaceuticals’ Brent Willis on creating the first vertically integrated medical radiological contrast media supplier in NA

In a recent InvestorIntel interview, Tracy Weslosky spoke with Brent Willis, President and CEO of Voyageur Pharmaceuticals Ltd. (TSXV: VM) about […]


Canada’s Voyageur Pharmaceuticals Breaking a Chinese Monopoly

In a recent InvestorIntel interview, Jack Lifton spoke with Brent Willis, President and CEO of Voyageur Pharmaceuticals Ltd. (TSXV: VM) […]


Brent Willis on Voyageur Pharmaceuticals’ competitive suite of barium radiographic contrast media products

In a recent InvestorIntel interview, Chris Thompson speaks with Brent Willis, President and CEO of Voyageur Pharmaceuticals Ltd. (TSXV: VM) […]


Voyageur Pharmaceuticals’ Supply Chain Security Advantage – From the Earth to the Bottle

With all the warnings issued in articles posted on InvestorIntel about rare earth supply security, the whole Suez Canal mess […]


High-Grade Barium Project Creates High-Value Opportunity for Voyageur Pharmaceuticals

Voyageur Pharmaceuticals Ltd. (TSXV: VM) (Voyageur) is a Canadian-based company that is focused on developing barium and iodine radio-contrast pharmaceutical […]